Robert Alan Lepley

Robert Alan Lepley

Analyst-Equity en
TIS Group, Inc. (Research)
.
Consumer Services
Finance

Perfil

Dr. Robert A. Lepley is Research Strategist at TIS Group, Inc. He joined the firm in September 2000.
At TIS Group, his principal areas of research are biopharmaceutics and healthcare, energy (hydrocarbon and alternative), country-specific macro analyses (natural resources group and Asia), and geostrategic analyses (emerging market focus).
Dr. Lepley was previously employed as a research scientist in the pharmaceutical industry and as a university faculty member.
He has published his scientific work in peer-reviewed, high-impact scientific journals such as the Journal of Biological Chemistry and the Journal of Clinical Investigation, as well as in book chapters.
With more than 20 years of professional experience in biomedical research, he is thoroughly familiar with the biomedical research and development landscape for drugs, medical devices, and diagnostics encompassing preclinical research, the FDA clinical trial process, and intellectual property considerations.
His professional experience includes Parke-Davis Pharmaceutical Research, the University of Colorado Health Sciences Center, Upjohn Pharmaceuticals, and the University of Minnesota.
Dr. Lepley holds a B.S.
and a Ph.D.
from the University of Minnesota.

Cargos activos de Robert Alan Lepley

EmpresasCargoInicio
TIS Group, Inc. (Research)
Analyst-Equity 01/09/2000

Antiguos cargos conocidos de Robert Alan Lepley.

EmpresasCargoFin
Parke-Davis Pharmaceutical Research, Inc.
Corporate Officer/Principal -
Corporate Officer/Principal -
Analyst-Equity -
Ver el detalle de la experiencia de Robert Alan Lepley.

Formación de Robert Alan Lepley.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

92

Relaciones de 1er grado

5

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas5

Finance

Consumer Services

Consumer Services

Parke-Davis Pharmaceutical Research, Inc.

TIS Group, Inc. (Research)

  1. Bolsa de valores
  2. Insiders
  3. Robert Alan Lepley